Alopecia Associated With Treatment With Selective Serotonin Reuptake Inhibitors (SSRIs)

    January 2006 in “ Pharmacoepidemiology and drug safety ”
    Karin Hedenmalm, Anders Sundström, Olav Spigset
    Image of study
    TLDR SSRIs can cause hair loss, especially sertraline, with higher risk in women.
    The study investigated the link between alopecia and SSRIs using data from SWEDIS and Vigibase, identifying 27 reports of alopecia, predominantly in women (88.9%). Sertraline had a significantly higher reporting rate of alopecia compared to citalopram (20.1 vs. 4.5 reports per million patient-years). Sertraline was significantly associated with alopecia in both databases, while citalopram was only significant in Vigibase. No significant associations were found for other SSRIs. The study concluded that alopecia is a rare adverse reaction to SSRIs, with varying risks among different SSRIs and a potentially higher risk in women. Hair regrowth after discontinuing or reducing SSRIs suggested a dose-dependent effect.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 1000+ results

      community EU Shouldn't Ban Fin & Dut: PFS is NOT REAL.

      in Research/Science  11 upvotes 9 months ago
      Finasteride and Dutasteride do not cause depression or "Post Finasteride Syndrome," with concerns often linked to the nocebo effect and preexisting mental health issues. The EU is unlikely to ban these drugs, but access may become more restricted due to ongoing debates.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  64 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

      community The mechanism of androgenic alopecia

      in Research/Science  32 upvotes 1 week ago
      DHT may inhibit hair growth by affecting mitochondrial function, leading to hair follicle miniaturization. Treatments like minoxidil and PP405 may promote hair growth by altering metabolic pathways, potentially counteracting DHT's effects.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 3 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

      community Pyrilutamide ,the molecule’s true nature

      in Research  302 upvotes 1 year ago
      Pyrilutamide is a selective AR antagonist with a high binding affinity, making it effective in competing with DHT for androgen receptors. The 1% concentration is more effective than the 0.5%, but the latter may suffice for mild hair loss; the drug is considered a good option for those avoiding 5AR blockers due to side effects.

      community Why is human evolution like this 😂

      in Chat 3 years ago
      Why androgenic alopecia affects the scalp rather than other body parts, potential explanations for this phenomenon, treatments available to combat hair loss, and the implications of male attractiveness in modern society.

    Related Research

    1 / 1 results